News InterCure Ltd.

Equities

INCR

IL0011063760

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 15:24:14 27/06/2024 BST			5-day change	1st Jan Change
792.8 ^ILa	-2.94%		+0.89%	+71.19%

05-01	InterCure Ltd. Provides Revenue Guidance for the Full Year 2024	CI
05-01	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference	05-22	BU
InterCure : Immediate Report	05-21	PU
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million	05-01	BU
InterCure Ltd. Provides Revenue Guidance for the Full Year 2024	05-01	CI
InterCure : FORM 20-F For the fiscal year ended December 31, 2023	05-01	PU
InterCure : Announces FY2023 Result	05-01	PU
InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	05-01	CI
InterCure : Preliminary results for the full year of 2023	04-01	PU
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million	04-01	BU
InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023	04-01	CI
InterCure : Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million - Form 6-K	04-01	PU
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint	03-22	BU
InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months	03-22	CI
InterCure Provides an Update Regarding Nir Oz Facility	02-13	AQ
InterCure Ltd. Announces Resignation of Rami Levy as Chief of Operations	02-13	CI
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain	01-31	AQ
InterCure Ltd. entered into a share purchase agreement to acquire Leon Pharm Ltd for ILS 8.3 million.	01-30	CI
InterCure : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023 - Form 6-K	11-08	PU
InterCure Wins Cannolam Arbitration Proceeding	31/10/23	AQ
InterCure Provides an Update Regarding the Security Situation in Israel	17/10/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News InterCure Ltd.

Equities

INCR

IL0011063760

Summary

Filters